SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-008899
Filing Date
2017-08-10
Accepted
2017-08-10 17:00:37
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 430150
2 ex10-3.htm EX-10.3 14976
3 ex31-1.htm EX-31.1 20413
4 ex32-1.htm EX-32.1 8088
  Complete submission text file 0001493152-17-008899.txt   2097816

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE vbio-20170630.xml EX-101.INS 281751
6 XBRL SCHEMA FILE vbio-20170630.xsd EX-101.SCH 26123
7 XBRL CALCULATION FILE vbio-20170630_cal.xml EX-101.CAL 31710
8 XBRL DEFINITION FILE vbio-20170630_def.xml EX-101.DEF 81952
9 XBRL LABEL FILE vbio-20170630_lab.xml EX-101.LAB 200677
10 XBRL PRESENTATION FILE vbio-20170630_pre.xml EX-101.PRE 153509
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53832 | Film No.: 171022144
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9